June 2, 2005 — The U.S. Food and Drug Administration (FDA) has approved extended-release dexmethylphenidate HCl capsules for once-daily treatment of attention deficit/hyperactivity disorder in adults, ...

Drug firm Aurobindo Pharma has received final approval from the US health regulator for Meropenem injection used for treatment of complicated skin and related infections, complicated intra abdominal ...

Share price of Aurobindo Pharma rose 2 percent intraday Tuesday on USFDA approval for Meropenem Injection. The company has received final approval from the US Food & Drug Administration (USFDA) to ...

Brooks Laboratories Limited’s subsidiary Brooks Steriscience Limited, (BSL) has received approval from the United States Food & Drug Administration (USFDA) for Meropenem Injection 500mg per vial and ...

Meropenem 0.5-g a and 1-g b vials were used to prepare 4-mg/mL solutions. Each 0.5-g vial was reconstituted with 10 mL of sterile water for injection (SWFI) and each 1-g vial with 20 mL of SWFI to ...